Zobrazeno 1 - 10
of 633
pro vyhledávání: '"miR-222"'
Autor:
Touba Eslaminejad, Seyed Noureddin Nematollahi-Mahani, Marzieh Lotfian Sargazi, Mehdi Ansari, Vida Mirzaie
Publikováno v:
Diagnostic Pathology, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background Breast cancer is one of the most common diseases worldwide that affects women of reproductive age. miR-221 and miR-222 are two highly homogeneous microRNAs that play pivotal roles in many cellular processes and regulate the Wnt/β
Externí odkaz:
https://doaj.org/article/50c69e5a21a94a5cb96c50425f955f9d
Publikováno v:
International Journal of Women's Health, Vol Volume 14, Pp 1681-1689 (2022)
Aviwe Ntsethe, Irene Mackraj Department of Human Physiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South AfricaCorrespondence: Irene Mackraj; Aviwe Ntsethe, Department of Human Physiology, University
Externí odkaz:
https://doaj.org/article/9d60af010a3c4747b0853447d18cb4db
Autor:
Yaser Masoumi-Ardakani, Hamid Najafipour, Hamid Reza Nasri, Soheil Aminizadeh, Shirin Jafari, Zohreh Safi
Publikováno v:
Cell Journal, Vol 24, Iss 10, Pp 577-585 (2022)
Objective: Hypertension (HTN) is among the leading causes of myocardial infarction, stroke, and kidney disease. TheMitoQ supplement is a mitochondrial-targeted antioxidant that attenuates the generation of reactive oxygen species (ROS). miRNAs play a
Externí odkaz:
https://doaj.org/article/6352e98a2adc4e3f8c9ddf90a2aec4d6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Central European Journal of Immunology, Vol 46, Iss 1, Pp 17-26 (2021)
Systemic lupus erythematosus (SLE), a complex polygenic autoimmune disease, is associated with increased complement activation. Complement factor H related protein 5 (CFHR5) may contribute to dysfunctional complement activation, thus predisposing to
Externí odkaz:
https://doaj.org/article/1d46a844fa9740dc8f73515bcbf96116
Autor:
Chiara Tupini, Matteo Zurlo, Jessica Gasparello, Irene Lodi, Alessia Finotti, Thomas Scattolin, Fabiano Visentin, Roberto Gambari, Ilaria Lampronti
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1332 (2023)
Combined treatments employing lower concentrations of different drugs are used and studied to develop new and more effective anticancer therapeutic approaches. The combination therapy could be of great interest in the controlling of cancer. Regarding
Externí odkaz:
https://doaj.org/article/c8172d0bf8a8415a81a2c3d8e42afc6b
Autor:
Sadeghzadeh S, Dehghani Ashkezari M, Seifati SM, Vahidi Mehrjardi MY, Dehghan Tezerjani M, Ladan SAB
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 13, Pp 3461-3469 (2020)
Salman Sadeghzadeh,1 Mahmood Dehghani Ashkezari,1 Seyed Morteza Seifati,1 Mohammad Yahya Vahidi Mehrjardi,2,3 Masoud Dehghan Tezerjani,4 Sara Sadeghzadeh,5 Seyed Amir Behtash Ladan1 1Medical Biotechnology Research Center, Ashkezar Branch, Islamic Aza
Externí odkaz:
https://doaj.org/article/aee9ace69b804bd1a6808cec9382cb71
Publikováno v:
Cellular & Molecular Biology Letters, Vol 25, Iss 1, Pp 1-16 (2020)
Abstract Background Pulmonary arterial hypertension (PAH) is often characterized by cell proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs). LncRNA cancer susceptibility candidate 2 (CASC2) has been revealed to be involved
Externí odkaz:
https://doaj.org/article/322910c9d8dc4830ad17050b36336662
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Qiulian Zhou, Jiali Deng, Jianhua Yao, Jiaxin Song, Danni Meng, Yujiao Zhu, Minjun Xu, Yajun Liang, Jiahong Xu, Joost PG Sluijter, Junjie Xiao
Publikováno v:
EBioMedicine, Vol 74, Iss , Pp 103713- (2021)
Background: Exercise can protect myocardial infarction (MI) and downregulate cardiac Homeodomain-Interacting Protein Kinase 2 (HIPK2). However, the role of HIPK2 in MI is unclear. Methods: HIPK2–/– mice and miR-222–/– rats, HIPK2 inhibitor (P
Externí odkaz:
https://doaj.org/article/0ca37ec124dc49cdadbe6ad4e0e1f44c